首页 > 最新文献

International journal of heart failure最新文献

英文 中文
Epicardial Adipose Tissue (Pericoronary Adipose Tissue) in Cardiovascular Diseases. 心血管疾病中的心外膜脂肪组织(冠状动脉周围脂肪组织)。
Pub Date : 2025-10-31 eCollection Date: 2025-10-01 DOI: 10.36628/ijhf.2025.0080
Eun Jeong Cho
{"title":"Epicardial Adipose Tissue (Pericoronary Adipose Tissue) in Cardiovascular Diseases.","authors":"Eun Jeong Cho","doi":"10.36628/ijhf.2025.0080","DOIUrl":"10.36628/ijhf.2025.0080","url":null,"abstract":"","PeriodicalId":101410,"journal":{"name":"International journal of heart failure","volume":"7 4","pages":"240-242"},"PeriodicalIF":0.0,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12611219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145515344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Salt and Structure: Linking Hyponatremia to Cardiac Dysfunction in Critical Heart Failure. 盐和结构:将低钠血症与危重心衰心功能障碍联系起来。
Pub Date : 2025-10-29 eCollection Date: 2025-10-01 DOI: 10.36628/ijhf.2025.0079
Leonardo Paskah Suciadi
{"title":"Salt and Structure: Linking Hyponatremia to Cardiac Dysfunction in Critical Heart Failure.","authors":"Leonardo Paskah Suciadi","doi":"10.36628/ijhf.2025.0079","DOIUrl":"10.36628/ijhf.2025.0079","url":null,"abstract":"","PeriodicalId":101410,"journal":{"name":"International journal of heart failure","volume":"7 4","pages":"254-256"},"PeriodicalIF":0.0,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12611216/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145515398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sodium-Glucose Cotransporter 2 Inhibitors-Induced Euglycemic Ketoacidosis Mimicking Myocardial Infarction in a Non-Diabetic Heart Failure Patient. 非糖尿病性心力衰竭患者钠-葡萄糖共转运蛋白2抑制剂诱导的正糖酮症酸中毒模拟心肌梗死
Pub Date : 2025-10-24 eCollection Date: 2025-10-01 DOI: 10.36628/ijhf.2025.0048
KilYoon Pack, Kyung Eun Ha, Taeil Yang, Wook-Jin Chung
{"title":"Sodium-Glucose Cotransporter 2 Inhibitors-Induced Euglycemic Ketoacidosis Mimicking Myocardial Infarction in a Non-Diabetic Heart Failure Patient.","authors":"KilYoon Pack, Kyung Eun Ha, Taeil Yang, Wook-Jin Chung","doi":"10.36628/ijhf.2025.0048","DOIUrl":"10.36628/ijhf.2025.0048","url":null,"abstract":"","PeriodicalId":101410,"journal":{"name":"International journal of heart failure","volume":"7 4","pages":"257-260"},"PeriodicalIF":0.0,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12611215/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145515453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Echocardiographic Correlates of Hyponatremia in Critically Ill Patients With Heart Failure. 心衰危重患者低钠血症的超声心动图相关性研究。
Pub Date : 2025-10-23 eCollection Date: 2025-10-01 DOI: 10.36628/ijhf.2025.0057
Anan Younis, Meir Tabi, Kianoush B Kashani, Garima Dahiya, Maan Jokhadar, Dustin B Hillerson, Ruben Crespo-Diaz, Jacob C Jentzer

Background and objectives: Few data have examined cardiac function correlates of hyponatremia in heart failure (HF) patients. We examined the association between hyponatremia and echocardiographic parameters with outcomes among HF patients in the cardiac intensive care unit (CICU).

Methods: Retrospective analysis of 3,372 Mayo Clinic CICU patients with HF from 2007 to 2018 grouped according to admission serum sodium: severe hyponatremia (sodium <130 mEq/L, 6%), mild hyponatremia (sodium 130-134 mEq/L, 16%), normal (sodium 135-144 mEq/L, 78%). Echocardiographic findings and mortality were compared across groups.

Results: The median age was 71.8 years old, and 39% were females. Patients with hyponatremia had worse echocardiographic parameters reflecting left ventricular (LV) systolic function and forward flow, particularly stroke volume index and LV systolic work index, with higher right atrial pressure and worse right ventricular-pulmonary artery coupling. In-hospital mortality occurred in 12.4% and increased with more severe hyponatremia: ≥135 mEq/L, 10.8%; 130-134 mEq/L, 16.7%; <130 mEq/L, 21.6% (p<0.001). One-year mortality occurred in 32.1% and was higher in patients with hyponatremia: ≥135 mEq/L, 29.6%; 130-134 mEq/L, 40.7%; <130 mEq/L, 40.7% (p<0.001). Patients with hyponatremia had significantly higher in-hospital (adjusted odds ratio, 1.80; 95% confidence interval [CI], 1.44-2.25; p<0.001) and one-year (adjusted hazard ratio, 1.51; 95% CI, 1.32-1.72; p<0.001) mortality, both overall and when stratified by echocardiographic measures. Additive increases in mortality were seen in patients with hyponatremia and poor echocardiographic hemodynamics.

Conclusions: CICU patients with HF and hyponatremia have worse hemodynamics reflected by echocardiographic parameters of LV systolic and diastolic function and forward flow, plus worse right ventricular function, with resultant worse clinical outcomes.

背景和目的:很少有资料研究心力衰竭(HF)患者低钠血症与心功能的相关性。我们研究了在心脏重症监护病房(CICU)的心衰患者中低钠血症和超声心动图参数与预后之间的关系。方法:回顾性分析2007 - 2018年梅奥诊所收治的3372例心衰CICU患者,按入院时血清钠:重度低钠血症(sodium)分组结果:中位年龄71.8岁,女性占39%。低钠血症患者反映左室收缩功能和前流的超声心动图参数较差,尤其是卒中容积指数和左室收缩功指数,右房压较高,右心室-肺动脉耦合较差。住院死亡率为12.4%,随着低钠血症的加重而增加:≥135 mEq/L, 10.8%;130-134 mEq/L, 16.7%;结论:心衰合并低钠血症的CICU患者左室收缩舒张功能及前流超声心动图参数反映的血流动力学较差,右室功能较差,导致临床预后较差。
{"title":"Echocardiographic Correlates of Hyponatremia in Critically Ill Patients With Heart Failure.","authors":"Anan Younis, Meir Tabi, Kianoush B Kashani, Garima Dahiya, Maan Jokhadar, Dustin B Hillerson, Ruben Crespo-Diaz, Jacob C Jentzer","doi":"10.36628/ijhf.2025.0057","DOIUrl":"10.36628/ijhf.2025.0057","url":null,"abstract":"<p><strong>Background and objectives: </strong>Few data have examined cardiac function correlates of hyponatremia in heart failure (HF) patients. We examined the association between hyponatremia and echocardiographic parameters with outcomes among HF patients in the cardiac intensive care unit (CICU).</p><p><strong>Methods: </strong>Retrospective analysis of 3,372 Mayo Clinic CICU patients with HF from 2007 to 2018 grouped according to admission serum sodium: severe hyponatremia (sodium <130 mEq/L, 6%), mild hyponatremia (sodium 130-134 mEq/L, 16%), normal (sodium 135-144 mEq/L, 78%). Echocardiographic findings and mortality were compared across groups.</p><p><strong>Results: </strong>The median age was 71.8 years old, and 39% were females. Patients with hyponatremia had worse echocardiographic parameters reflecting left ventricular (LV) systolic function and forward flow, particularly stroke volume index and LV systolic work index, with higher right atrial pressure and worse right ventricular-pulmonary artery coupling. In-hospital mortality occurred in 12.4% and increased with more severe hyponatremia: ≥135 mEq/L, 10.8%; 130-134 mEq/L, 16.7%; <130 mEq/L, 21.6% (p<0.001). One-year mortality occurred in 32.1% and was higher in patients with hyponatremia: ≥135 mEq/L, 29.6%; 130-134 mEq/L, 40.7%; <130 mEq/L, 40.7% (p<0.001). Patients with hyponatremia had significantly higher in-hospital (adjusted odds ratio, 1.80; 95% confidence interval [CI], 1.44-2.25; p<0.001) and one-year (adjusted hazard ratio, 1.51; 95% CI, 1.32-1.72; p<0.001) mortality, both overall and when stratified by echocardiographic measures. Additive increases in mortality were seen in patients with hyponatremia and poor echocardiographic hemodynamics.</p><p><strong>Conclusions: </strong>CICU patients with HF and hyponatremia have worse hemodynamics reflected by echocardiographic parameters of LV systolic and diastolic function and forward flow, plus worse right ventricular function, with resultant worse clinical outcomes.</p>","PeriodicalId":101410,"journal":{"name":"International journal of heart failure","volume":"7 4","pages":"243-253"},"PeriodicalIF":0.0,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12612606/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145544297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tailoring Management of Heart Failure With Preserved Ejection Fraction Through Sex-Specific Insights. 通过性别特异性观察保留射血分数的心力衰竭的定制管理。
Pub Date : 2025-10-20 eCollection Date: 2025-10-01 DOI: 10.36628/ijhf.2025.0074
Hack-Lyoung Kim
{"title":"Tailoring Management of Heart Failure With Preserved Ejection Fraction Through Sex-Specific Insights.","authors":"Hack-Lyoung Kim","doi":"10.36628/ijhf.2025.0074","DOIUrl":"10.36628/ijhf.2025.0074","url":null,"abstract":"","PeriodicalId":101410,"journal":{"name":"International journal of heart failure","volume":"7 4","pages":"227-228"},"PeriodicalIF":0.0,"publicationDate":"2025-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12611217/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145515457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Applications of Speckle-Tracking Echocardiography in Heart Failure: From Diagnosis to Prognostication. 斑点跟踪超声心动图在心力衰竭中的临床应用:从诊断到预测。
Pub Date : 2025-10-16 eCollection Date: 2025-10-01 DOI: 10.36628/ijhf.2025.0052
Ju-Hee Lee, Jae-Hyeong Park

Speckle-tracking echocardiography (STE) has emerged as a valuable noninvasive tool for assessing myocardial deformation in patients with heart failure (HF). This review summarizes the principles, clinical applications, and prognostic implications of strain echocardiography across the spectrum of HF phenotypes, including heart failure with reduced ejection fraction (HFrEF), mildly reduced ejection fraction (HFmrEF), and preserved ejection fraction (HFpEF). Global longitudinal strain (GLS) provides a more sensitive and reproducible measure of left ventricular (LV) systolic function than traditional echocardiographic parameter like LV ejection fraction (EF), enabling early detection of subclinical dysfunction in stage A and B HF. In HFrEF, LVGLS adds incremental prognostic value beyond LVEF and identifies patients at risk for adverse outcomes. In HFmrEF, it helps characterize disease trajectory, guide therapy, and predict LVEF deterioration. In HFpEF, LVGLS uncovers subtle systolic impairment and stratifies risk. Additionally, left atrial (LA) and right ventricular (RV) strain measurements are increasingly recognized as important indicators of chamber-specific dysfunction and predictors of mortality, HF hospitalization, and atrial fibrillation. Despite vendor variability and the lack of universally accepted cut-offs, STE is becoming integral to HF evaluation. Pattern recognition of myocardial strains, such as apical sparing in amyloidosis, adds diagnostic value in cardiomyopathies. The integration of strain parameters enhances risk stratification, facilitates early diagnosis, and aids therapeutic monitoring in HF. Further standardization and broader clinical adoption of STE are needed to fully harness its prognostic and diagnostic capabilities in HF management.

斑点跟踪超声心动图(STE)已成为评估心力衰竭(HF)患者心肌变形的一种有价值的无创工具。本文综述了各种心力衰竭表型(包括心力衰竭伴射血分数降低(HFrEF)、轻度射血分数降低(HFmrEF)和保留射血分数(HFpEF))的原理、临床应用和预后意义。与传统超声心动图参数(如左室射血分数(EF))相比,全局纵向应变(GLS)对左室(LV)收缩功能的测量更为敏感和可重复性,能够早期发现a期和B期HF的亚临床功能障碍。在HFrEF中,LVGLS增加了LVEF之外的增量预后价值,并识别出有不良结局风险的患者。在HFmrEF中,它有助于表征疾病轨迹,指导治疗,并预测LVEF恶化。在HFpEF中,LVGLS发现了微妙的收缩损伤,并对风险进行了分层。此外,左心房(LA)和右心室(RV)应变测量越来越被认为是房室特异性功能障碍的重要指标,也是死亡率、HF住院率和房颤的预测指标。尽管供应商存在差异,并且缺乏普遍接受的截止值,STE正在成为HF评估不可或缺的一部分。心肌毒株的模式识别,如淀粉样变的根尖保留,增加了心肌病的诊断价值。应变参数的整合增强了风险分层,便于早期诊断,并有助于心衰的治疗监测。STE需要进一步标准化和更广泛的临床应用,以充分利用其在心衰管理中的预后和诊断能力。
{"title":"Clinical Applications of Speckle-Tracking Echocardiography in Heart Failure: From Diagnosis to Prognostication.","authors":"Ju-Hee Lee, Jae-Hyeong Park","doi":"10.36628/ijhf.2025.0052","DOIUrl":"10.36628/ijhf.2025.0052","url":null,"abstract":"<p><p>Speckle-tracking echocardiography (STE) has emerged as a valuable noninvasive tool for assessing myocardial deformation in patients with heart failure (HF). This review summarizes the principles, clinical applications, and prognostic implications of strain echocardiography across the spectrum of HF phenotypes, including heart failure with reduced ejection fraction (HFrEF), mildly reduced ejection fraction (HFmrEF), and preserved ejection fraction (HFpEF). Global longitudinal strain (GLS) provides a more sensitive and reproducible measure of left ventricular (LV) systolic function than traditional echocardiographic parameter like LV ejection fraction (EF), enabling early detection of subclinical dysfunction in stage A and B HF. In HFrEF, LVGLS adds incremental prognostic value beyond LVEF and identifies patients at risk for adverse outcomes. In HFmrEF, it helps characterize disease trajectory, guide therapy, and predict LVEF deterioration. In HFpEF, LVGLS uncovers subtle systolic impairment and stratifies risk. Additionally, left atrial (LA) and right ventricular (RV) strain measurements are increasingly recognized as important indicators of chamber-specific dysfunction and predictors of mortality, HF hospitalization, and atrial fibrillation. Despite vendor variability and the lack of universally accepted cut-offs, STE is becoming integral to HF evaluation. Pattern recognition of myocardial strains, such as apical sparing in amyloidosis, adds diagnostic value in cardiomyopathies. The integration of strain parameters enhances risk stratification, facilitates early diagnosis, and aids therapeutic monitoring in HF. Further standardization and broader clinical adoption of STE are needed to fully harness its prognostic and diagnostic capabilities in HF management.</p>","PeriodicalId":101410,"journal":{"name":"International journal of heart failure","volume":"7 4","pages":"201-215"},"PeriodicalIF":0.0,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12611220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145515353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pericoronary Adipose Tissue as a Predictor of Diastolic Dysfunction: A New Paradigm in Coronary Artery Disease Assessment. 冠状动脉周围脂肪组织作为舒张功能障碍的预测因子:冠状动脉疾病评估的新范式。
Pub Date : 2025-10-01 DOI: 10.36628/ijhf.2025.0032
Ritika Agarwal, Jahnavi Gaduputi, Karthik R Shetty, Neeraj Shivakumar, V S Prakash

Background and objectives: Pericoronary adipose tissue (PCAT) is linked to coronary artery disease (CAD) progression through compositional changes that disrupt adipose homeostasis and affect vascular biology. This study explores how PCAT characteristics - volume and fat attenuation index (FAI)-relate to CAD severity and left ventricular (LV) function.

Methods: This study included 100 patients with suspected CAD who underwent coronary computed tomography angiography (CCTA) and echocardiography between September 2023 and July 2024. PCAT volume, FAI and thickness were measured along coronary arteries (right coronary artery [RCA], left anterior descending [LAD], and left circumflex [LCX]). CAD severity was assessed using the Gensini score, while LV structural and functional metrics, including diastolic function, were obtained via echocardiography. Correlations between PCAT parameters, CAD burden, and LV function were analyzed using Spearman's correlation and p value <0.05 was considered significant.

Results: RCA FAI exhibited the strongest association with CAD severity (Gensini score: r=0.416, p=0.026) and diastolic dysfunction (r=0.536, p<0.001), with progressively less negative values from Grade 1 to Grade 3 dysfunction. LAD and LCX (r=0.278, p=0.03) FAI displayed moderate associations. RCA volume correlated with LV mass index, fractional shortening and diastolic parameters. Hypertension was associated with elevated RCA FAI and volume (p<0.05), while diabetes showed no significant impact on PCAT metrics.

Conclusions: PCAT FAI is a sensitive marker of CAD severity and diastolic dysfunction, especially in the RCA, highlighting its value for detection, risk stratification, and personalized CAD management. Integration of PCAT metrics into routine CCTA analysis could enhance cardiovascular risk assessment and treatment planning.

背景和目的:冠状动脉周围脂肪组织(PCAT)与冠状动脉疾病(CAD)进展有关,其组成改变可破坏脂肪稳态并影响血管生物学。本研究探讨PCAT特征-体积和脂肪衰减指数(FAI)-与CAD严重程度和左心室(LV)功能的关系。方法:本研究纳入了100例疑似CAD患者,这些患者于2023年9月至2024年7月期间接受了冠状动脉ct血管造影(CCTA)和超声心动图检查。沿冠状动脉(右冠状动脉[RCA]、左前降支[LAD]、左旋支[LCX])测量PCAT体积、FAI和厚度。使用Gensini评分评估CAD严重程度,而通过超声心动图获得左室结构和功能指标,包括舒张功能。结果:RCA FAI与CAD严重程度(Gensini评分:r=0.416, p=0.026)和舒张功能障碍(r=0.536, p)的相关性最强。结论:PCAT FAI是CAD严重程度和舒张功能障碍的敏感指标,特别是在RCA,突出了其在检测、风险分层和个性化CAD管理方面的价值。将PCAT指标整合到常规CCTA分析中可以提高心血管风险评估和治疗计划。
{"title":"Pericoronary Adipose Tissue as a Predictor of Diastolic Dysfunction: A New Paradigm in Coronary Artery Disease Assessment.","authors":"Ritika Agarwal, Jahnavi Gaduputi, Karthik R Shetty, Neeraj Shivakumar, V S Prakash","doi":"10.36628/ijhf.2025.0032","DOIUrl":"10.36628/ijhf.2025.0032","url":null,"abstract":"<p><strong>Background and objectives: </strong>Pericoronary adipose tissue (PCAT) is linked to coronary artery disease (CAD) progression through compositional changes that disrupt adipose homeostasis and affect vascular biology. This study explores how PCAT characteristics - volume and fat attenuation index (FAI)-relate to CAD severity and left ventricular (LV) function.</p><p><strong>Methods: </strong>This study included 100 patients with suspected CAD who underwent coronary computed tomography angiography (CCTA) and echocardiography between September 2023 and July 2024. PCAT volume, FAI and thickness were measured along coronary arteries (right coronary artery [RCA], left anterior descending [LAD], and left circumflex [LCX]). CAD severity was assessed using the Gensini score, while LV structural and functional metrics, including diastolic function, were obtained via echocardiography. Correlations between PCAT parameters, CAD burden, and LV function were analyzed using Spearman's correlation and p value <0.05 was considered significant.</p><p><strong>Results: </strong>RCA FAI exhibited the strongest association with CAD severity (Gensini score: r=0.416, p=0.026) and diastolic dysfunction (r=0.536, p<0.001), with progressively less negative values from Grade 1 to Grade 3 dysfunction. LAD and LCX (r=0.278, p=0.03) FAI displayed moderate associations. RCA volume correlated with LV mass index, fractional shortening and diastolic parameters. Hypertension was associated with elevated RCA FAI and volume (p<0.05), while diabetes showed no significant impact on PCAT metrics.</p><p><strong>Conclusions: </strong>PCAT FAI is a sensitive marker of CAD severity and diastolic dysfunction, especially in the RCA, highlighting its value for detection, risk stratification, and personalized CAD management. Integration of PCAT metrics into routine CCTA analysis could enhance cardiovascular risk assessment and treatment planning.</p>","PeriodicalId":101410,"journal":{"name":"International journal of heart failure","volume":"7 4","pages":"229-239"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12612604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145544280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex Differences in 90-Day Readmission and Mortality Trends in Heart Failure With Preserved Ejection Fraction: Insights From the National Readmissions Database. 保留射血分数的心力衰竭患者90天再入院和死亡率趋势的性别差异:来自国家再入院数据库的见解
Pub Date : 2025-09-25 eCollection Date: 2025-10-01 DOI: 10.36628/ijhf.2025.0029
Usman Ahmed, Huma Hussain, Shirin Saeed, Adil Al-Karim Manji, Juan Valencia, Rayaan Yunus, Mark Robitaille, Guanqing Chen, Feroze Mahmood, Robina Matyal

Background and objectives: Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure hospitalizations and disproportionately affects women, who present with distinct risk profiles and pathophysiologies compared to men. Prior studies exploring sex differences have been limited by small sample sizes and have often focused on index hospitalizations. We aimed to examine sex differences in risk factors, causes of readmission, and mortality following HFpEF hospitalization using a large, nationally representative cohort.

Methods: We performed a retrospective cohort study using the 2016-2019 National Readmissions Database. Adults hospitalized with a primary diagnosis of HFpEF were included. Patients were followed for 90-day readmissions, and multivariable logistic regression was used to identify predictors of readmission and readmission-related mortality, stratified by sex. The final sample included 353,536 patients (217,354 women and 136,182 men).

Results: Women were older at admission, more likely to live in lower-income areas, and more often presented with uncomplicated hypertension, while men had a higher burden of ischemic heart disease. Advancing age was associated with increased risk of readmission in women. Women were more frequently readmitted with respiratory failure, diastolic heart failure, and atrial fibrillation, suggesting a greater burden of vascular stiffness and symptom severity. Chronic kidney disease and diabetes were key predictors of readmission and mortality in both sexes.

Conclusions: HFpEF manifests with distinct sex-specific risk factors, clinical trajectories, and outcomes. These findings underscore the need for sex-informed, individualized treatment strategies and equitable resource allocation to reduce disparities and improve outcomes in HFpEF care.

背景和目的:保留射血分数的心力衰竭(HFpEF)占所有心力衰竭住院患者的近一半,并且不成比例地影响女性,与男性相比,女性表现出不同的风险概况和病理生理。先前对性别差异的研究受到样本量小的限制,而且往往集中在指数住院治疗上。我们的目的是通过一个具有全国代表性的大型队列研究HFpEF住院后的危险因素、再入院原因和死亡率的性别差异。方法:我们使用2016-2019年国家再入院数据库进行了一项回顾性队列研究。初步诊断为HFpEF的住院成年人被纳入研究。对患者进行90天的再入院随访,并采用多变量logistic回归来确定再入院和再入院相关死亡率的预测因素,按性别分层。最终样本包括353536名患者(217354名女性和136182名男性)。结果:女性在入院时年龄较大,更可能生活在低收入地区,更常出现无并发症的高血压,而男性有更高的缺血性心脏病负担。年龄增长与女性再入院风险增加有关。女性因呼吸衰竭、舒张性心力衰竭和心房颤动而再次入院的频率更高,这表明血管僵硬和症状严重程度的负担更大。慢性肾脏疾病和糖尿病是两性再入院和死亡率的主要预测因素。结论:HFpEF具有明显的性别特异性危险因素、临床轨迹和结局。这些发现强调了性别知情、个性化治疗策略和公平资源分配的必要性,以减少差异并改善HFpEF治疗的结果。
{"title":"Sex Differences in 90-Day Readmission and Mortality Trends in Heart Failure With Preserved Ejection Fraction: Insights From the National Readmissions Database.","authors":"Usman Ahmed, Huma Hussain, Shirin Saeed, Adil Al-Karim Manji, Juan Valencia, Rayaan Yunus, Mark Robitaille, Guanqing Chen, Feroze Mahmood, Robina Matyal","doi":"10.36628/ijhf.2025.0029","DOIUrl":"10.36628/ijhf.2025.0029","url":null,"abstract":"<p><strong>Background and objectives: </strong>Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure hospitalizations and disproportionately affects women, who present with distinct risk profiles and pathophysiologies compared to men. Prior studies exploring sex differences have been limited by small sample sizes and have often focused on index hospitalizations. We aimed to examine sex differences in risk factors, causes of readmission, and mortality following HFpEF hospitalization using a large, nationally representative cohort.</p><p><strong>Methods: </strong>We performed a retrospective cohort study using the 2016-2019 National Readmissions Database. Adults hospitalized with a primary diagnosis of HFpEF were included. Patients were followed for 90-day readmissions, and multivariable logistic regression was used to identify predictors of readmission and readmission-related mortality, stratified by sex. The final sample included 353,536 patients (217,354 women and 136,182 men).</p><p><strong>Results: </strong>Women were older at admission, more likely to live in lower-income areas, and more often presented with uncomplicated hypertension, while men had a higher burden of ischemic heart disease. Advancing age was associated with increased risk of readmission in women. Women were more frequently readmitted with respiratory failure, diastolic heart failure, and atrial fibrillation, suggesting a greater burden of vascular stiffness and symptom severity. Chronic kidney disease and diabetes were key predictors of readmission and mortality in both sexes.</p><p><strong>Conclusions: </strong>HFpEF manifests with distinct sex-specific risk factors, clinical trajectories, and outcomes. These findings underscore the need for sex-informed, individualized treatment strategies and equitable resource allocation to reduce disparities and improve outcomes in HFpEF care.</p>","PeriodicalId":101410,"journal":{"name":"International journal of heart failure","volume":"7 4","pages":"216-226"},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12612605/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145544235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left Ventricular Assist Device Support in Duchenne Dilated Cardiomyopathy: Case Series of the First Three Patients in South Korea. 左心室辅助装置支持杜氏扩张型心肌病:韩国前三例患者的病例系列。
Pub Date : 2025-09-04 eCollection Date: 2025-10-01 DOI: 10.36628/ijhf.2025.0051
Soo Yong Lee, Jinhong Shin, Soo-Yeon Kim, Yeon Ju Rhee, Min Ho Ju
{"title":"Left Ventricular Assist Device Support in Duchenne Dilated Cardiomyopathy: Case Series of the First Three Patients in South Korea.","authors":"Soo Yong Lee, Jinhong Shin, Soo-Yeon Kim, Yeon Ju Rhee, Min Ho Ju","doi":"10.36628/ijhf.2025.0051","DOIUrl":"10.36628/ijhf.2025.0051","url":null,"abstract":"","PeriodicalId":101410,"journal":{"name":"International journal of heart failure","volume":"7 4","pages":"261-265"},"PeriodicalIF":0.0,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12611218/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145515420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reviving the Failing Heart: Contractile Reserve and Remodeling Reversal. 复苏衰竭的心脏:收缩储备和重塑逆转。
Pub Date : 2025-07-30 eCollection Date: 2025-07-01 DOI: 10.36628/ijhf.2025.0056
Hyemoon Chung
{"title":"Reviving the Failing Heart: Contractile Reserve and Remodeling Reversal.","authors":"Hyemoon Chung","doi":"10.36628/ijhf.2025.0056","DOIUrl":"10.36628/ijhf.2025.0056","url":null,"abstract":"","PeriodicalId":101410,"journal":{"name":"International journal of heart failure","volume":"7 3","pages":"160-161"},"PeriodicalIF":0.0,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12318856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144791252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of heart failure
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1